Subsequent to the letter to Chief Justice of India by Campaign for Affordable Trastuzumab stating concerns regarding IP Owners Association (IPOA) with India judiciary , we have heard from the credible sources that IPOA’s meeting with IPAB and Delhi High Court have been summarily cancelled.
Campaign for Affordable Trastuzumab wrote to Chief Justice of India raising concern about “Innovation Dialog” being organised in India from November 16-22, 2014 by the Intellectual Property Owners Association (IPOA). The campaign specifically mentioned about IPOA’s proposed meetings with representatives of the IPAB, the Delhi High Court and the Patent Controller’s offices, as these institutions are in the process of hearing patent-related cases that could involve IPOA members and questioned the ethics and propriety of meetings and interactions between the judiciary and the IPOA delegation.
The letter sent by Campaign for Affordable Trastuzumab can be accessed here
To view the agenda of IPOA meeting, click here.
Department of Industrial Policy & Promotion (DIPP), Ministry of Commerce, India along with Confederation of Indian Industries and Intellectual Property India (IPO) is holding an international conference on “IP Law and Enforcement” in Noida, 20-21 Nov 2014. Access the agenda of the conference here.
This conference raises concerns on IP and public interest as well as a Government of India’s established stand of balanced approach to intellectual protection and enforcement. Government of India in all international and domestic forum has always taken a firm stand to balance the IP protection and enforcement, a private interest with the public interest i.e. access to medicines, access to knowledge, access to technology etc. The conference is a clear departure from this stand and the agenda is completely IP Maximalist. The agenda seem to accommodate only corporations and law firms and have excluded academia and civil society organisations.
Source: MSF Access Campaign
New Delhi, 25 November 2014—As US Trade Representative Michael Froman meets high-ranking Indian officials to likely pressure the government to weaken its pro-public health patent law, Doctors Without Borders/ Médecins Sans Frontières (MSF) urged the new Indian Prime Minister to take a strong stand against weakening a law that has helped millions of people in India and across the developing world get access to affordable life-saving medicines. Continue reading
Posted in access to medicines, Compulsory Licensing, Injunctions, Innovation, Intellectual Property, IP Rights, Novartis Case, Out of Cycle Review (OCR), patent, Right to Health, Sec 3 (d), Trade Policy Forum, TRIPS plus, US pressure on India, USTR 301 report
Source: Economic Times
NEW DELHI: India and the US have agreed to step up bilateral engagement, building on the progress made after the two countries recently reached a landmark deal to break the deadlock at the WTO, but did not report any progress on contentious issues at the ministerial-level meeting in Delhi on Tuesday. Officials from the two countries will hold as many as 20 face-to-face or video conferences before the next meeting of the India-US trade policy forum (TPF) next year to reach agreement on enhanced market access for farm products, common ground on contentious intellectual property rights and also visa and totalisation issues important to Indian professionals. Continue reading
Posted in access to medicines, Innovation, Intellectual Property, IP Rights, IPR policy, Out of Cycle Review (OCR), patent, Right to Health, Trade Policy Forum, TRIPS plus, US pressure on India, USTR 301 report, WTO
Tagged Bilateral trade, Copyright, visa issues
Source: Business Today
India and the United States on Tuesday decided to explore the possibility of giving greater market access to agricultural products and continue engagement on visa and social security totalisation issues concerning Indian IT professionals and intellectual property rights (IPR) covering pharma patents. Continue reading
Posted in access to medicines, Innovation, Intellectual Property, IP Rights, IPR policy, Out of Cycle Review (OCR), patent, Trade Policy Forum, TRIPS plus, US pressure on India, USTR 301 report
Source: Business Standard
The discussion took place under the much-awaited India-US Trade Policy Forum
The US asked India on Tuesday to take steps to aid affordable health care by looking beyond intellectual property rights (IPR) and compulsory licensing and addressing other concerns such as rate reduction, distribution of medicines and insurance coverage.
The discussion took place under the India-US Trade PolicyForum (TPF), which met here on Tuesday after a gap of more than four years, with both sides seeking to address outstanding issues concerning bilateral trade and investment. Continue reading
Posted in access to medicines, Compulsory Licensing, Innovation, IP Rights, IPR policy, Out of Cycle Review (OCR), Right to Health, Trade Policy Forum, TRIPS plus, US pressure on India, USTR 301 report, WTO
Source: Business Standard
Raising concerns that issues related to Intellectual Property Rights (IPR) were impeding their bilateral trade, the US today asked India to look more closely at its IPR norms and address this problem mutually.
A day before the Trade Policy Forum meeting with Commerce and Industry Minister Nirmala Sitharaman, the US Trade Representative Michael Froman today told the representatives of Indian industry that India and the US need to explore collaborative and creative solutions to resolve IPR-related issues that were impeding bilateral trade. Continue reading
Source: Business Standard
India was Tuesday urged by the US to look beyond intellectual property rights (IPR) and compulsory licensing in affordable healthcare, and to address concerns like tariff reduction, distribution of medicines and insurance coverage.
“There is a lot that goes into access to affordable healthcare beyond intellectual property rights, beyond patents, beyond compulsory licenses,” US Trade Representative Michael Froman said after a meeting of the India-US Trade Policy Forum (TPF) here. Continue reading